SUBSCRIBE
SUBSCRIBE
News   Drug Development

Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmonary Anti-Fibrotic Effect Demonstrated

July 6, 2011 | 
1 min read
TEMPE, Ariz., July 6, 2011 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) (the "Company") today announced results from a pre-clinical study of AZX100 in a rodent model of radiation-induced pulmonary fibrosis.
Preclinical
MORE ON THIS TOPIC
An obstacle to achieving a goal. Concerns and issues. Break through the refusal barrier. Face problems and challenges.
Prostate cancer
AstraZeneca’s Truqap Posts Another Pivotal Disappointment as Phase III Prostate Cancer Study Fails
April 30, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage with business concept. Career success concept, business goal,achieve goal, progress in career, make efforts to grow professionally. Teamwork. Hand finish ladder, helping to climb higher. Template for web banner, social media banner. Vector illustration
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
April 29, 2025
 · 
2 min read
 · 
Tristan Manalac
A monoclonal antibody (mAb or moAb) is an antibody made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a unique parent cell. Coronavirus. 3d render
Bladder cancer
Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint
April 28, 2025
 · 
1 min read
 · 
Tristan Manalac
Hands holding bladder, cystitis, urethritis and Urinary Incontinence, bladder cancer concept
Bladder cancer
J&J Declares ‘Sustained Disease Control’ With Bladder Cancer Drug-Device Combo
April 28, 2025
 · 
2 min read
 · 
Tristan Manalac